Your browser doesn't support javascript.
loading
Imaging Mass Spectrometry (IMS) for drug discovery and development survey: Results on methods, applications and regulatory compliance.
Solon, Eric; Groseclose, M Reid; Ho, Stacy; Tanaka, Kouji; Nakada, Naoyuki; Linehan, Stefan; Nishidate, Masanobu; Yokoi, Hiroyuki; Kaji, Hidefumi; Urasaki, Yoko; Watanabe, Kenichi; Ishida, Tomomi; Komatsu, Rika; Yoshida, Kenji; Yamazaki, Hiroshi; Saito, Kosuke; Saito, Yoshiro; Tanaka, Yukari.
Afiliación
  • Solon E; Member of Executive Committee, Imaging Mass Spectrometry Society (IMSS), Madrigal Pharmaceuticals, Inc., Four Tower Bridge, 200 Barr Harbor Drive, West Conshohocken, PA, 19428, USA. Electronic address: eric.solon@madrigalpharma.com.
  • Groseclose MR; Member of Executive Committee, IMSS, GlaxoSmithKline, 1250 S, Collegeville Rd., Collegeville, PA, 19426, USA. Electronic address: reid.x.groseclose@gsk.com.
  • Ho S; Member of Executive Committee, IMSS, Drug Metabolism and Pharmacokinetics, Pharmaceutical Sciences, Roche Innovation Center Shanghai (RICS), Building 5, No. 371, Lishizhen Road, Pudong New Area, Shanghai, China. Electronic address: stacy.ho@roche.com.
  • Tanaka K; Member of Japan Association for Imaging Mass Spectrometry, DMPK Research Laboratories, Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan. Electronic address: tanaka.kouji@ma.mt-pharma.co.jp.
  • Nakada N; Member of Japan Association for Imaging Mass Spectrometry, Analysis&Pharmacokinetics Research Labs., Drug Discovery Research, Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan. Electronic address: naoyuki.nakada@astellas.com.
  • Linehan S; Asia-Pacific (APAC) Outreach Liaison, IMSS Boston, MA, USA. Electronic address: stefan.linehan@gmail.com.
  • Nishidate M; Member of Japan Association for Imaging Mass Spectrometry, Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan. Electronic address: nishidate.masanobu@chugai-pharm.co.jp.
  • Yokoi H; Member of Japan Association for Imaging Mass Spectrometry, Drug Metabolism and Pharmacokinetics Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima, 771-0192, Japan. Electronic address: Yokoi.Hiroyuki@otsuka.jp.
  • Kaji H; Member of Japan Association for Imaging Mass Spectrometry, Drug Development Service Segment, LSI Medience Corporation13-4, Uchikanda 1-chome, Chiyoda-ku, Tokyo, 101-8517, Japan. Electronic address: kaji.hidefumi@mh.medience.co.jp.
  • Urasaki Y; Member of Japan Association for Imaging Mass Spectrometry, Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan. Electronic address: urasaki.yoko.j8@daiichisankyo.co.jp.
  • Watanabe K; Member of Japan Association for Imaging Mass Spectrometry, Preclinical Research Unit, Sumitomo Dainippon Pharma Co.,Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan. Electronic address: kenichi-watanabe@ds-pharma.co.jp.
  • Ishida T; Member of Japan Association for Imaging Mass Spectrometry, Global Drug Metabolism and Pharmacokinetics, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan. Electronic address: t6-ishida@hhc.eisai.co.jp.
  • Komatsu R; Member of Japan Association for Imaging Mass Spectrometry, Laboratory for Drug Discovery Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation.632-1 Mifuku, Izunokuni, Shizuoka, 410-2321, Japan. Electronic address: harada.rb@om.asahi-kasei.co.jp.
  • Yoshida K; Member of Japan Association for Imaging Mass Spectrometry, Drug Development Solutions Planning Department, Pharmaceutical Sciences Division, Sekisuimedical Co., Ltd., 2117 Muramatsu, Tokai, Ibaraki, 319-1182. Electronic address: kenji.yoshida@sekisui.com.
  • Yamazaki H; Member of Japan Association for Imaging Mass Spectrometry, Showa Pharmaceutical University, 3-3165 Higashi-tamagawa Gakuen, Machida, Tokyo, 194-8543, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.
  • Saito K; Member of Japan Association for Imaging Mass Spectrometry, Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan. Electronic address: saitok2@nihs.go.jp.
  • Saito Y; Member of Japan Association for Imaging Mass Spectrometry, Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan. Electronic address: yoshiro@nihs.go.jp.
  • Tanaka Y; Leader of Japan Association for Imaging Mass Spectrometry, Drug Metabolism and Pharmacokinetics, Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., 3-1-1, Futaba, Toyonaka, Osaka, 561-0825, Japan. Electronic address: yukari.tanaka@shionogi.co.jp.
Drug Metab Pharmacokinet ; 43: 100438, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35091331
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diagnóstico por Imagen / Descubrimiento de Drogas Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Revista: Drug Metab Pharmacokinet Asunto de la revista: FARMACOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diagnóstico por Imagen / Descubrimiento de Drogas Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Revista: Drug Metab Pharmacokinet Asunto de la revista: FARMACOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article